Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ontogen's OC144-093 reported at AACR meeting to merit further clinical testing

April 15, 1999

TAS-106, a promising antitumor nucleoside profiled at AACR meeting

April 15, 1999

News from AACR: Abbott researchers report findings on farnesyltransferase inhibitors

April 15, 1999

Profile of ZD-4190, a potent VEGF receptor tyrosine kinase inhibitor and antiangiogenic agent

April 15, 1999

In vitro and in vivo antitumor effects of noscapine discussed at AACR meeting

April 15, 1999

Novel water-soluble camptothecin analogue suitable for formulation in liposomes

April 15, 1999

Sugen presents preclinical data for SU-6668 at AACR meeting

April 15, 1999

PEG-rMETase, a promising new approach to cancer therapy

April 15, 1999

Potent and specific FTase inhibitor presented by Biomeasure

April 15, 1999

Merck presents protein farnesyltransferase inhibitor in phase I testing

April 15, 1999

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...